Skip to content

Regenerative Medical Technology Group Inc.

RMTG

CIK 0001760026

← back to feed
Revenue (TTM)
$6.17M
+24.2% YoY Q1 Jun 2026
Net Income (TTM)
−$7.3M
−40.4% YoY Q1 Jun 2026
EPS Diluted (TTM)
−$0.58
−40.9% YoY Q1 Jun 2026
Gross Margin
61.6%
Q1 Jun 2026
Operating Margin
-5.4%
Q1 Jun 2026
Net Margin
-118.3%
Q1 Jun 2026
Free Cash Flow (TTM)
−$328.61K
Q1 Jun 2026
Cash
$1.06M
Q1 Jun 2026
Total Debt
$4
Q1 Jun 2026
Shares Outstanding
13.14M sh
Q1 Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings